Notizie AIOM – anno XVII
ASCO Seeks Applicants for Research Grants to Use Data from CancerLinQ Discovery
February 20, 2019 - The American Society of Clinical Oncology (ASCO) announced today that it is seeking applications for research grants for projects that use data from CancerLinQ Discovery®, an offering of ASCO's CancerLinQ® initiative, as a source. CancerLinQ Discovery® ...Leggi tutto
FDA Approves Adjuvant Pembrolizumab in Stage III Melanoma
February 19, 2019 - The FDA has approved the PD-1 inhibitor pembrolizumab for the adjuvant treatment of patients with high-risk stage III melanoma with lymph node involvement following complete resection. This is the first anti–PD-1 therapy evaluated in the adjuvant ...Leggi tutto
FDA Grants Polatuzumab Vedotin Priority Review for DLBCL
February 19, 2019 - The FDA has granted a priority review designation to polatuzumab vedotin for use in combination with bendamustine and rituximab (BR) for the treatment of patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL), according to Genentech (Roche), ...Leggi tutto